Arcalis Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Arcalis Inc. Real-time updates on events, politics, business and more.

Arcturus Therapeutics : Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan

June 30, 2023

Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan Meiji Holdings Co., Ltd. Announces that...

Seika Pharma Arcalis Inc Arcturus Therapeutics Inc Axcelead Inc Meiji Seika Pharma Co Ltd Arcturus Therapeutics Holdings Inc

Source: marketscreener.com

Arcturus Therapeutics : Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan - Form 8-K

April 28, 2023

Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan Meiji Holdings Co., Ltd. announces... | April 28, 2023

Republic Of Seika Pharma Arcalis Inc Arcturus Therapeutics Holdings Inc Arcturus Therapeutics Inc Meiji Seika Pharma Co Ltd

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Arcalis Inc News Today

Arcturus Therapeutics : Additional Application for Booster Dose of ARCT-154, Self-Amplifying mRNA Vaccine against COVID-19, Submitted in Japan

Arcturus Therapeutics : Submitted New Drug Application to Manufacture and Market ARCT-154, Next Generation mRNA Vaccine against COVID-19, in Japan - Form 8-K

Explore More Categories